HomeInsightsEPS

Zydus Lifesciences Ltd EPS

Zydus Lifesciences Ltd EPS

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

8.0 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

EPS

₹ 41.43

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Zydus Lifesciences Ltd is ₹ 41.43 as of 07 Nov 24.
  • The Earning per Share of Zydus Lifesciences Ltd changed from ₹ 5.06 to ₹ 14.11 over 9 quarters. This represents a CAGR of 57.74% .

Historical Earning per Share of Zydus Lifesciences Ltd

No data available

* All values are in

Company Fundamentals for Zydus Lifesciences Ltd

Market Cap

97,866 Cr

EPS

41.4

P/E Ratio (TTM) *

23.5

P/B Ratio (TTM) *

4.9

Day’s High *

980.85

Day’s Low

968.85

DTE *

0.0

ROE *

19.5

52 Week High

1323.9

52 Week Low

598.05

ROCE *

22.7

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024972.6
06 Nov 2024995
05 Nov 2024989.3
04 Nov 20241004.3
01 Nov 20241004
31 Oct 20241001.85
30 Oct 2024985.55
29 Oct 20241002.3
28 Oct 20241006.65
25 Oct 2024990.2

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

97,866

Asset Value

15,429

5.3 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Zydus Lifesciences Ltd4197,866
Sun Pharmaceuticals Industries Ltd464,29,841
Divis Laboratories Ltd631,58,179
Cipla Ltd571,27,063
Mankind Pharma Ltd521,09,234
Dr Reddys Laboratories Ltd631,07,398

Historical Market Cap of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences to table results

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Nove...

Read more

31 Oct 202411:58

News

Zydus Life rises on in-principle approval from WHO for typhoid vaccine

ZyVac TCV is now eligible for purchase by United Nations (UN) agencies. It is indigenously...

Read more

23 Oct 202414:50

News

Zydus receives USFDA approval for Fludrocortisone Acetate Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

18 Oct 202409:29

News

Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab

Fludrocortisone Acetate tablets are indicated as partial replacement therapy for primary a...

Read more

18 Oct 202412:47

News

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of...

Read more

15 Oct 202410:08

News

Zydus Life gets final approval from USFDA for Paliperidone drug

Paliperidone extended-release tablets are indicated for the acute and maintenance treatmen...

Read more

10 Oct 202414:51

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Sep 2021

Transcript

Jan 2021

PPT

Aug 2020

PPT

Feb 2020

PPT

FAQs for EPS of Zydus Lifesciences Ltd

What is the EPS of Zydus Lifesciences Ltd stock?

The Earnings Per Share (EPS) of Zydus Lifesciences Ltd is 41.43. An EPS is the amount of net income attributed to each share of a common stock.

How is Zydus Lifesciences Ltd EPS calculated?

The EPS of Zydus Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Zydus Lifesciences Ltd report its EPS?

Zydus Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Zydus Lifesciences Ltd EPS?

Factors that influence the EPS of Zydus Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Zydus Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Zydus Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*